Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Atrial Fibrillation

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

J Am Heart Assoc

Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators

doi: 10.1161/JAHA.125.044293

Atrial Fibrillation

Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis

J Am Coll Cardiol

Pabon MA, Filippatos G, Claggett BL, Miao MZ, Desai AS, Jhund PS, Henderson A, Brinker M, Schloemer P, Hofmeister L, Li L, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M

doi: 10.1016/j.jacc.2025.03.429

Atrial Fibrillation

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Clin Res Cardiol

Menichelli D, Gazzaniga G, Poli D, Palareti G, Antonucci E, Pani A, Pignatelli P, Pastori D, START2 Register Investigators

doi: 10.1007/s00392-025-02765-7

Atrial Fibrillation

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Eur Heart J

Raveendra K, Nadarajah R, Larvin H, Farooq M, Haris M, Cutting U, Kang J, Wilkinson C, Dalakoti M, Kotecha D, Lip GYH, Boriani G, Camm AJ, Van Gelder IC, Wu J, Gale CP

doi: 10.1093/eurheartj/ehag021

Atrial FibrillationHeart Failure

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Heart Rhythm

Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, Hsu JC, Atwater B, Yang E, Spertus J, Calkins H, Freeman JV

doi: 10.1016/j.hrthm.2025.06.048

Atrial Fibrillation

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Cardiovasc Diabetol

Meulendijks ER, Fabrizi B, Bruns S, Eringa EC, Hoebe R, van den Boogert T, Wesselink R, Al-Shama RFM, de Vries TAC, Ernault AC, Niessen HWM, van Boven WJP, Driessen AHG, Zbairi I, Zappala P, Dey D, Isgum I, Planken RN, Krul SPJ, de Groot JR

doi: 10.1186/s12933-025-02985-1

Atrial FibrillationThrombosis and Stroke

Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction - an analysis of the UK Biobank

Heart Rhythm

Virk SA, Ho WWH, Takeuchi F, Morris GM, Kistler PM, Kalman J

doi: 10.1016/j.hrthm.2025.04.055

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial FibrillationTherapy and Intervention

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

JAMA Cardiol

Patel SM, Giugliano RP, Morrow DA, Goodrich EL, Murphy SA, Hug B, Parkar S, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Bloomfield D, Sabatine MS, Ruff CT

doi: 10.1001/jamacardio.2025.3393

Related content

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction - an analysis of the UK Biobank

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial